The neuroendocrine carcinoma component of gastric mixed adenoneuroendocrine carcinoma could develop with MLH1 deficiency independent of TP53 mutation
Pathology International · 2023
DOI: 10.1111/pin.13324 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pathology International, 2023. Verfasst von Rei Hashimoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Chiba University Hospital, Chiba, Japan. Hauptthemen laut MEDLINE: Adenocarcinoma, Carcinoma, Neuroendocrine, Stomach Neoplasms. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Chiba University Hospital, Chiba, Japan.
- Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan.
ORCID-Profile: Keisuke Matsusaka
Zitieren
APA
Hashimoto, R., Matsusaka, K., Matsumura, T., Hayano, K., Kato, N., Matsubara, H., & Ikeda, J. I. (2023). The neuroendocrine carcinoma component of gastric mixed adenoneuroendocrine carcinoma could develop with MLH1 deficiency independent of TP53 mutation. Pathology International. https://doi.org/10.1111/pin.13324
Vancouver
Hashimoto R, Matsusaka K, Matsumura T, Hayano K, Kato N, Matsubara H, et al. The neuroendocrine carcinoma component of gastric mixed adenoneuroendocrine carcinoma could develop with MLH1 deficiency independent of TP53 mutation. Pathology International. 2023. doi:10.1111/pin.13324
BibTeX
@article{Hashimoto2023,
author = {Hashimoto, Rei and Matsusaka, Keisuke and Matsumura, Tomoaki and Hayano, Koichi and Kato, Naoya and Matsubara, Hisahiro and Ikeda, Jun-Ichiro},
title = {The neuroendocrine carcinoma component of gastric mixed adenoneuroendocrine carcinoma could develop with MLH1 deficiency independent of TP53 mutation},
journal = {Pathology International},
year = {2023},
doi = {10.1111/pin.13324}
}
EUVIMED